AID Logo

Directory >> Jeffrey T. Schouten, MD


Jeffrey T. Shouten, MD photo

Contact Information

Jeffrey T. Schouten, MD

  • Clinical Associate Professor, Division of Allergy & Infectious Diseases, Dept. of Medicine and
  • Department of Surgery
  • University of Washington

    Staff Scientist
    Director, Office of HIV/AIDS Network Coordination (HANC)
    Fred Huchinson Cancer Research Center

    Attending Physician, Madison Clinic
    Harborview Medical Center

As the Director of HANC, Dr. Schouten provides leadership and strategic direction for all of the cross-network coordination activities that the HANC project encompasses. He works closely with the Network Leaders and the Division of AIDS (DAIDS) of the NIH to develop and implement strategies to coordinate activities and optimize collaboration between the networks and DAIDS and other funding and operational partners. The networks  include the AIDS Clinical Trials Group (ACTG), the HIV Prevention Trials Network (HPTN), the HIV Vaccine Trials Network (HVTN), the International Maternal Pediatric Adolescent AIDS Clinical Trials group (IMPAACT), the International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), and the Microbicide Trials Network (MTN). Jeff has been the HANC Director since September 2008. He is a former general surgeon with a focus on surgical oncology. He has been involved in HIV clinical research and HIV primary care for more than a decade. Jeff also has a strong interest in HIV public policy.

Selected Publications

Schouten JT, Schiffer JT. Equal HIV-1 decay kinetics in HSV-2-infected and HSV-2-uninfected clinical trial participants treated with antiretroviral therapy. J Acquir Immune Defic Syndr. 2012; 60(1): 68-71.
PubMed Abstract

Rosas SR, Kagan JM, Schouten JT, Slack PA, Trochim WM. Evaluating research and impact: A bibliometric analysis of research by the NIH/NIAID HIV/AIDS clinical trials networks. PLoS One. 2011; 6(3): e17428.
PLoS One Abstract

Ribaudo HJ, Benson CA, Zheng Y, Koletar SL, Collier AC, Lok JJ, Smurzynski M, Bosch RJ, Bastow B, Schouten JT. No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001/ALLRT. Clin Infect Dis. 2011; 52(7): 929-40.
PubMed Abstract

Krishnan S, Schouten JT, Jacobson DL, Benson CA, Collier AC, Koletar SL, Santana J, Sattler FR, Mitsuyasu R. Incidence of non-AIDS-defining cancer in antiretroviral treatment-nave subjects after antiretroviral treatment initiation: an ACTG longitudenal linked randomized trials analysis. Oncology. 2011; 80(1-2): 42-9.
PubMed Abstract

Schouten JT, Krambrink A, Ribaudo HJ, Kmack A, Webb N, Shikuma C, Kuritzkes DR, Gulick RM. Substitution of nevirapine because of efavirenz toxicity in AIDS clinical trials group A5095. Clin Infect Dis. 2010; 50(5): 787-91.
PubMed Abstract

Heath L, Fox A, McClure J, Diem K, van 't Wout AB, Zhao H, Park DR, Schouten JT, Twigg HL, Corey L, Mullins JI, Mittler JE. Evidence for limited genetic compartmentalization of HIV-1 between lung and blood. PLoS One. 2009; 4(9): e6949.
PubMed Abstract

to top